Skip to main content

CVS Maximum Strength Cold and Flu Relief

NDC 69842-903 · CVS PHARMACY

Generic nameAcetaminophen, Dextromethorphan Hydrobromide, Guaifenesin ,Phenylephrine HCL
Dosage formLIQUID
RouteORAL
Active ingredient(s)ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE
Strength650; 20; 400; 10 mg/20mL; mg/20mL; mg/20mL; mg/20mL
Pharmacologic classAdrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
Marketing categoryOTC MONOGRAPH DRUG

Packages

69842-903-06 — 180 mL in 1 BOTTLE, PLASTIC (69842-903-06)

69842-903-09 — 266 mL in 1 BOTTLE, PLASTIC (69842-903-09)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

69842-812 — guaifenesin, dextromethorphan HBr, 69842-819 — Dextromethorphan HBr, Guaifenesin, 69842-847 — ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, 69842-848 — ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl, 69842-864 — Acetaminophen, 69842-876 — Acetaminophen, 69842-878 — Acetaminophen, 69842-886 — Acetaminophen, Dextromethorphan HBr, Triprolidine HCl, 69842-897 — ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL, 69842-899 — ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, 69842-904 — Dextromethorphan Hydrobromide Guaifenesin, 69842-915 — Acetaminophen, 69842-926 — Dextromethorphan HBr, Guaifenesin, 69842-930 — Acetaminophen, 69842-931 — Acetaminophen, 69842-933 — Guaifenesin, Dextromethorphan HBr, 69842-937 — Dextromethorphan HBr and Guaifenesin, 69842-942 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 69842-947 — Acetaminophen, Dextromethorphan HBr, 69842-956 — Acetaminophen, Diphenhydramine HCl, +5267 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.